Clinical Trials Browser

Phase 1 × Advanced Urothelial Carcinoma × pembrolizumab × Clear all

NCT05929235 2026-01-30

A Study of FX-909 in Patients With Advanced Solid Malignancies, Including Advanced Urothelial Carcinoma

Phase 1 Recruiting

Advanced Urothelial Carcinoma